Comparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons

ObjectiveThe 2019 Asian Working Group on Sarcopenia in Older People (AWGS 2019) recommends using either calf circumference or the strength, assistance in walking, rising from a chair, climbing stairs, and falls (SARC-F) or SARC-F combined with calf circumference (SARC-CalF) questionnaires for sarcopenia screening. The aim of this study was to compare the ability and applicability of calf circumference, SARC-F, and SARC-CalF for screening sarcopenia among community-dwelling older adults.DesignCross-sectional study.Setting and ParticipantsA total of 1050 community-dwelling older people were enrolled.MethodsSarcopenia was diagnosed according to the AWGS 2019 criteria: bioimpedance analysis for appendicular skeletal muscle index, hand grip, and 6-m gait speed test. Participants also completed the SARC-F questionnaire and calf circumference measurement. The screening tools’ performances were evaluated through receiver operating characteristic (ROC) curves, area under the ROC curves (AUC), and sensitivity/specificity analyses.ResultsSarcopenia was identified in 263 (25.0%) participants by the AWGS 2019 criteria. Calf circumference had a sensitivity of 81.4% and a specificity of 77.0%. Sensitivity and specificity of SARC-F for screening sarcopenia were 17.9% and 93.7%, respectively. SARC-CalF improved the sensitivity of SARC-F (47.5%) while keeping similar specificity (92.0%). The AUCs of calf circumference, SARC-F, and SARC-CalF were 0.79 [95% confidence interval (CI), 0.77–0.82], 0.56 (95% CI, 0.52–0.59), and 0.70 (95% CI, 0.67–0.73), respectively. The differences across ROC curves were statistically significant among 3 screening tools (P < .001).Conclusions and ImplicationsThe overall screening ability of calf circumference was better than that of SARC-F and SARC-CalF for sarcopenia in community-dwelling older persons despite gender, age, and cognitive function. SARC-F and SARC-CalF have high specificity but are susceptible to the preceding factors.     

纤维胆管镜治疗术后残余结石320例分析

（1）目的 总结320例胆管术后,经T管窦道纤维胆管镜治疗残余结石的经验。（2）方法 对320例胆管术后残余结石病人行纤维胆管镜取石,分析其临床表现并予以随访。（3）结果 结石取净287例,失败33例,（4）结论 纤维胆管镜对于术后胆管残余结石的治疗起着重要作用。     

IBA损伤老化鼠脑Meynert核的AD模型动物研究

目的研究定位损伤脑胆碱能系Alzheimer病(AD)模型大鼠学习能力及相关脑神经肽免疫组化改变.方法用兴奋性毒素鹅膏蕈氨酸(IBA)定位损伤大鼠脑右侧Meynert核,观察模型动物学习能力改变(Y型迷宫法),并用分光光度法和免疫组化染色法观察动物脑胆碱酯酶(AchE)活性和皮层及海马β-淀粉样肽前体(β-APP)、生长抑素(SOM)及P物质(SP)的表达情况.结果模型组老化大鼠经损伤后,学习能力及脑AchE活性显著低于对照组(P均＜0.05).β-APP在额叶皮层和海马的表达均升高,而S()M表达则显著减少,用IBA及β-AP25-35同时损伤鼠脑时,可显示脑皮质区SP表达增加(P均＜0. 01).单独用IBA注射无效.结论IBA损伤老化大鼠脑Meynert核建立的动物模型,显示胆碱能系统损伤,学习能力障碍,β-APP过表达而神经肽SOM表达降低,一定条件下SP表达增加,与AD病人某些临床和病理特征基本一致.     

重组血管生成抑制因子r—K4K5的分离纯化与功能鉴定

目的 分离纯化r-K4K5,探讨r-K4K5对牛毛血管内皮（BCE）细胞、鸡胚绒毛尿囊膜（CAM）新生血管生成及实验性人肺腺癌SPC-A1生长的抑制作用。方法 通过盐析、凝胶过滤提纯r-K4K5,BCE细胞在含r-K4K5的DMEM中培养24、48、72h后分别计数;孵化7d的鸡胚加r-K4K5后继续孵育72h,观察新生血管生成;已经接种入SPC-A1肺腺癌组织的荷瘤裸小鼠（Balb/c,nu/nu）,瘤旁注射r-K4K5继续饲养,观察肿瘤生长变化。结果 r-K4K5抑制BCE细胞增殖,48～72h作用明显;r-K4K5处理的CAM组中直径小于50um的小血管明显减少;高剂量r-K4K5治疗的荷瘤裸小鼠组,平均瘤重与对照组比较有统计学意义。结论 r-K4K5能够抑制BCE细胞增殖,抑制鸡胚CAM新生血管生成,抑制实验性人SPC-A1肺腺瘤生长。     

巩膜外冷凝联合巩膜扣带术治疗视网膜脱离

目的 研究巩膜外冷凝联合巩膜扣带术治疗视网膜脱离的疗效。方法 在视网膜裂孔对应的巩膜外冷凝、放出视网膜下液、巩外加压。结果 随诊1mo以上,35眼中,32眼达到解剖复位,成功率为91．43％。结论 巩膜外冷凝联合巩膜扣带术治疗视网膜脱离,手术操作简单,手术反应轻,疗效满意,是一理想的手术方法。     

肢体负压对周围动脉闭塞性病变犬皮肤SP免疫反应阳性神经纤维影响

目的　观察肢体负压对周围动脉闭塞性病变犬皮肤中 SP免疫反应阳性神经纤维的影响 .方法　犬 17只 ,随机分治疗组 10只、非治疗组 5只和正常对照组 2只 ,治疗组和非治疗组均将动物制作左后肢缺血模型 ,治疗组在模型制作后 14d,开始行患肢负压治疗 10 d(15 min·次 - 1 ) ;非治疗组不做负压治疗 ;正常对照组不行缺血模型制作及负压治疗 . 3组均行左后肢趾皮肤免疫组化染色 ,检测 SP免疫反应阳性纤维 .结果　非治疗组皮肤中 SP免疫反应阳性神经纤维均较正常对照组明显增多 (P<0 .0 1) ,治疗组较非治疗组减少(P<0 .0 1) ,但仍较正常对照组增多 .结论　肢体负压疗法可促进皮肤感觉神经纤维中 SP的释放